U.S. approves digital pill that tracks when patients take it - Digital Intent

PHARMA HEALTHCARE BIOTECH DIGITAL NEWS & VIEWS

Tuesday, 14 November 2017

U.S. approves digital pill that tracks when patients take it


U.S. regulators have approved the first digital pill with an embedded sensor to track if patients are taking their medication properly, marking a significant step forward in the convergence of healthcare and technology.
The medicine is a version of Otsuka Pharmaceutical Co Ltd’s established drug Abilify for schizophrenia, bipolar disorder and depression, containing a tracking device developed by Proteus Digital Health.
 Shares in Otsuka rose 2.5 percent on Tuesday after news of the U.S. Food and Drug Administration (FDA) late on Monday.

No comments:

Post a Comment